Dr Reddys Laboratories informs about disclosure

17 May 2025 Evaluate
Dr Reddys Laboratories has informed that the United States Food & Drug Administration (USFDA) completed a GMP inspection at its API Middleburgh facility in New York. The inspection was conducted from 12th May, 2025 to 16th May, 2025 (US EST time). They have been issued a Form 483 with 2 observations, which they will address within the stipulated timeline. 

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1241.10 23.95 (1.97%)
23-Jan-2026 11:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1630.45
Dr. Reddys Lab 1241.10
Cipla 1381.95
Zydus Lifesciences 888.40
Lupin 2152.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×